ISOPLEXIS CORPORATION

Bruker Cellular Analysis | Home

BRANFORD, United States · Founded 2015 · $11.4M raised

Employees
51–200
Founded
2015
Total Funding
$11.4M
Last Round
$2.0M GrantJun 2020
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

IsoPlexis developed functional proteomics platforms enabling single-cell protein analysis to characterize immune cell function for drug development and cancer immunotherapy research. The company's IsoLight and IsoSpark systems used proprietary CodePlex technology to measure polyfunctional immune cell responses at the single-cell level. IsoPlexis was acquired by Berkeley Lights in March 2023, forming the combined company PhenomeX (Nasdaq: CELL).

Summary

ISOPLEXIS CORPORATION is a Biotech company based in BRANFORD, United States, founded in 2015. It has raised $11.4M in total across 4 rounds, most recently a $2.0M Grant round in Jun 2020.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantSBIR Phase II (NIH)Jun 2020
$2.0M

Sign up to see all 4 events

Funding: Grant. Amounts, valuations, and investors where available.

Similar Companies

Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ISOPLEXIS CORPORATION on Indexed.vc
<a href="https://indexed.vc/companies/isoplexis-corporation"><img src="https://indexed.vc/api/badge/company/isoplexis-corporation" alt="ISOPLEXIS CORPORATION on Indexed.vc" width="260" height="76" /></a>